Evaluation of alloimmune responses in humanised NOD/SCID/IL2Rgnull mice following human CD34+stem cell transplantation

被引：0
|
作者：
Hartwig, U. F. [1 ]
Nonn, M. [1 ]
Khan, S. A. [1 ]
Brunk, A. [1 ]
Hemmerling, J. [1 ]
Meyer, R. G. [1 ]
Andre, M. C. [2 ]
Handgretinger, R. [2 ]
Huber, C. [1 ]
Herr, W. [1 ]
机构：
[1] Johannes Gutenberg Univ Mainz, Mainz, Germany
[2] Univ Tubingen, Tubingen, Germany
来源：
BONE MARROW TRANSPLANTATION | 2009年 / 43卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S156 / S156
页数：1
相关论文
共 50 条
  • [31] NOD-scid IL2rgnull (NSG) mice deficient in murine MHC Class I and Class II expression support engraftment of functional human T cells in the absence of acute xenogeneic GVHD following injection of PBMC
    Brehm, Michael A.
    Wiles, Michael
    Kenney, Laurie Lea
    Burzenski, Lisa
    Keck, James
    Greiner, Dale L.
    Shultz, Leonard D.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [32] Human dendritic cell subsets in NOD/SCID mice engrafted with CD34+ hematopoietic progenitors
    Palucka, AK
    Gatlin, J
    Blanck, JP
    Melkus, MW
    Clayton, S
    Ueno, H
    Kraus, ET
    Cravens, P
    Bennett, L
    Padgett-Thomas, A
    Marches, F
    Islas-Ohlmayer, M
    Garcia, JV
    Banchereau, J
    BLOOD, 2003, 102 (09) : 3302 - 3310
  • [33] NOD-scid IL2rgnull (NSG) mice deficient in murine MHC Class I and Class II expression support engraftment of functional human T cells in the absence of acute xenogeneic GVHD following injection of PBMC
    Brehm, Michael A.
    Wiles, Michael
    Kenney, Laurie
    Low, Ben
    Tisch, Roland M.
    Burzenski, Lisa
    Keck, James G.
    Greiner, Dale L.
    Shultz, Leonard D.
    CANCER RESEARCH, 2018, 78 (13)
  • [34] CD34+stem cell production in NOD/SCID chimeras is reduced early during ex vivo expansion of human CD34+umbilical cord blood stem cells, but not at later time points.
    Gilmore, GL
    Lister, J
    Shadduck, RK
    BLOOD, 2000, 96 (11) : 171A - 171A
  • [35] Human Delta Like 1-Expressing Human Mesenchymal Stem Cells Promote Human T Cell Development in Humanized NOD/SCID/IL-2rgnull (NSG)
    Kim, M.
    Choi, B.
    Chun, E.
    Park, H.
    Kim, S.
    Chah, K.
    Baik, K.
    Lee, K.
    Kim, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 320 - 320
  • [36] Stimulation of human CD34+hematopoetic stem cells (HSC) with SCF (stem cell factor) results in an increased engraftment in NOD/SCID mice
    Drewel, D
    Hart, C
    Müller, G
    Pissler, N
    Van Ryen, F
    Kunz-Schughart, L
    Holler, E
    Andreesen, R
    Hennemann, B
    EXPERIMENTAL HEMATOLOGY, 2003, 31 (07) : 187 - 187
  • [37] A novel human stem cell assay using neonatal NOD/SCID/IL2rγnull mice
    Ishikawa, Fumihiko
    Yoshida, Shuro
    Lyons, Bonnie
    Yasukawa, Masaki
    Harada, Mine
    Akashi, Koichi
    Shultz, Leonard D.
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S307 - S307
  • [38] Enhanced engraftment of human CD34+stem cells in NOD/SCID mice by diprotin a occurs by inhibition of recipient CD26/Dipeptidyl Peptidase-IV (DPP-IV).
    Kawai, Toshinao
    Choi, Uimook
    Liu, Po-Ching
    Malech, Harry L.
    BLOOD, 2006, 108 (11) : 907A - 907A
  • [39] Quantitative engraftment capacities of human CD34+ vs. CD34- stem/progenitor cells in nod/scid mice.
    Gao, ZG
    Lumkul, R
    Civin, CI
    BLOOD, 1999, 94 (10) : 31A - 31A
  • [40] The CD34(++) CD38(-) stem cell subfraction is responsible for the initiation of human acute myeloid leukemia in NOD-SCID mice.
    Bonnet, D
    Dick, JE
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 557 - 557
12345